Lilly Stock Jumps After Phase 3 Weight-Drug Readout
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
This quick guide highlights index funds with the lowest turnover, explaining how turnover impacts risk, taxes, and long-term gains.
26,958 articlesLilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Kalshi and Polymarket have launched a coordinated policy crackdown on paid influencers promoting election fraud claim...
After a prolonged rally, the AI-heavy trade just worst stretch put gains on pause. This article outlines three clear ...
Gordon Ritter argues that AI’s learning loop isn’t a job-killer countdown, but a shift toward human-driven innovation...
A June 2026 study highlights a paradox: many people believe they’re open to new ideas, but true financial resilience ...
A tech founder explains why he dismissed roughly 80% of his team after AI resistance and what it means for workers an...
A new Peterson Institute analysis argues that Trump turned dollar into a diplomatic tool, with potential ripple effec...
SpaceX and Google reportedly aim to place data centers in orbit. This article breaks down the idea, the economics, ri...
Fox faced a sharp weekly decline as it moved to acquire Roku. This article breaks down the catalysts, financing, and ...
A seasoned travel-points expert fell for a fake invitation, and thieves turned 330,000 miles into gift cards. This gu...
Stocks surged on unconfirmed chatter of an Apple chip deal with Intel, fueling bets on Intel’s foundry business. Anal...
Lockheed Martin stock down in a short span has sparked questions about the defense sector and broader markets. This g...